Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 May;15(5):1415-20.
doi: 10.1111/ajt.13130. Epub 2015 Mar 13.

Long-term lung transplantation in nonhuman primates

A Aoyama  1 , M Tonsho, C Y Ng, S Lee, T Millington, O Nadazdin, J C Wain, A B Cosimi, D H Sachs, R N Smith, R B Colvin, T Kawai, J C Madsen, G Benichou, J S Allan
Affiliations

Long-term lung transplantation in nonhuman primates

A Aoyama et al. Am J Transplant. 2015 May.

Abstract

Despite advances in surgical technique and clinical care, lung transplantation still remains a short-term solution for the treatment of end-stage lung disease. To date, there has been limited experience in experimental lung transplantation using nonhuman primate models. Therefore, we have endeavored to develop a long-term, nonhuman primate model of orthotopic lung transplantation for the ultimate purpose of designing protocols to induce tolerance of lung grafts. Here, we report our initial results in developing this model and our observation that the nonhuman primate lung is particularly prone to rejection. This propensity toward rejection may be a consequence of 1) upregulated nonspecific inflammation, and 2) a larger number of pre-existing alloreactive memory T cells, leading to augmented deleterious immune responses. Our data show that triple-drug immunosuppression mimicking clinical practice is not sufficient to prevent acute rejection in nonhuman primate lung transplantation. The addition of horse-derived anti-thymocyte globulin and a monoclonal antibody to the IL-6 receptor allowed six out of six lung recipients to be free of rejection for over 120 days.

Keywords: Immunosuppressant; animal models: nonhuman primate; basic (laboratory) research/science; fusion proteins and monoclonal antibodies; immunosuppressant; lung transplantation/pulmonology; polyclonal preparations.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Lung histology showing no evidence for rejection in an autotransplanted lung (#M4809, Day 35, H&E 50X).
Figure 2
Figure 2
Lung histology showing high-grade rejection of an MHC-mismatched lung in a nonimmunosuppressed recipient (#M3805, Day 5, Verhoeff’s stain 50X).
Figure 3
Figure 3
Lung histology showing healthy graft (#M4012 [Group 2], Day 96, H&E 50X).
Figure 4
Figure 4
Lung histology showing healthy graft (#M4209 [Group 3], Day 97, H&E 50X).
Figure 5
Figure 5
hATG+anti-IL6RmAb (n=3) have asynergistic effect on the expansion of circulating regulatory T cells, compared to either hATG (n=1) or anti-IL6R mAb (n=1) alone.
Figure 6
Figure 6
Transient increase in CD25+Foxp3+ T lymphocytes after treatment with hATG and anti-ILSR mAb (#M1407).
See this image and copyright information in PMC

References

    1. Yusen RD, Christie JD, Edwards LB, et al. The Registry of the International Society for Heart and Lung Transplantation: Thirtieth adult lung and heart-lung transplant report–2013; focus theme: Age. J Heart Lung Transplant. 2013;32:965–978. - PubMed
    1. Boskovic S, Kawai T, Smith RN, et al. Monitoring antidonor alloantibodies as a predictive assay for renal allograft tolerance/long-term observations in nonhuman primates. Transplantation. 2006;82:819–825. - PubMed
    1. Stewart S, Fishbein MC, Snell GI, et al. Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection. J Heart Lung Transplant. 2007;26:1229–1242. - PubMed
    1. Yamada Y, Boskovic S, Aoyama A, et al. Overcoming memory T-cell responses for induction of delayed tolerance in nonhuman primates. Am J Transplant. 2012;12:330–340. - PMC - PubMed
    1. Lee S, Yamada Y, Boskovic S, Atif M, Tonsho M, Nadazdin O, et al. Renal allograft tolerance can be achieved in non-human primates via delayed mixed-hematopoietic chimerism and alefacept treatment. Abstract , American Transplant Congress, Seattle, 2013, published in Am J Transplant. 2013;13:149.

Publication types

Substances